Skip to main content
TipRanks
Go Ultimate75% OFF
Saol Therapeutics logo

Saol Therapeutics: Valuation, Funding & Investors

A privately held, clinical-stage pharmaceutical company developing therapies for rare diseases and pain indications. Its pipeline includes SL1009 and SL1002, with a focus on launch preparation and lifecycle expansion.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$115M
Total Funding Rounds
1
Latest Funding Amount
$115M
Latest Funding Round
Investment

Main Enterprise Clients

A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Sep 15, 2026Investment$115.00M―

Investors

Investor NameFunding Round
OaktreeInvestment

Similar Companies

A snapshot of private companies similar to Saol Therapeutics, helping you discover and navigate related company profiles.

Related News and Analysis